INDO US BIO-TECH | NATURA HUE C | INDO US BIO-TECH/ NATURA HUE C |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.3 | 71.0 | 59.6% | View Chart |
P/BV | x | 8.6 | 0.3 | 2,946.1% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO US BIO-TECH NATURA HUE C |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-23 |
NATURA HUE C Mar-23 |
INDO US BIO-TECH/ NATURA HUE C |
5-Yr Chart Click to enlarge
|
||
High | Rs | 125 | 8 | 1,596.4% | |
Low | Rs | 25 | 4 | 642.7% | |
Sales per share (Unadj.) | Rs | 61.6 | 0.1 | 53,224.0% | |
Earnings per share (Unadj.) | Rs | 7.2 | -0.4 | -1,815.5% | |
Cash flow per share (Unadj.) | Rs | 8.0 | -0.4 | -2,022.7% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 54.3 | 25.0 | 216.9% | |
Shares outstanding (eoy) | m | 10.03 | 4.15 | 241.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 51.3 | 2.4% | |
Avg P/E ratio | x | 10.4 | -14.8 | -70.6% | |
P/CF ratio (eoy) | x | 9.4 | -14.8 | -63.4% | |
Price / Book Value ratio | x | 1.4 | 0.2 | 590.9% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 754 | 24 | 3,097.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 13 | 1 | 2,170.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 617 | 0 | 128,635.4% | |
Other income | Rs m | 0 | 0 | - | |
Total revenues | Rs m | 618 | 0 | 128,679.2% | |
Gross profit | Rs m | 94 | -2 | -5,762.6% | |
Depreciation | Rs m | 8 | 0 | - | |
Interest | Rs m | 12 | 0 | 120,100.0% | |
Profit before tax | Rs m | 74 | -2 | -4,504.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 0 | 14,600.0% | |
Profit after tax | Rs m | 72 | -2 | -4,387.9% | |
Gross profit margin | % | 15.2 | -340.4 | -4.5% | |
Effective tax rate | % | 2.0 | -0.5 | -361.3% | |
Net profit margin | % | 11.7 | -344.0 | -3.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 599 | 1 | 72,179.5% | |
Current liabilities | Rs m | 123 | 3 | 4,746.3% | |
Net working cap to sales | % | 77.1 | -366.9 | -21.0% | |
Current ratio | x | 4.9 | 0.3 | 1,520.7% | |
Inventory Days | Days | 1 | 81,924 | 0.0% | |
Debtors Days | Days | 146,261,410 | 0 | - | |
Net fixed assets | Rs m | 90 | 108 | 83.3% | |
Share capital | Rs m | 100 | 41 | 241.9% | |
"Free" reserves | Rs m | 445 | 63 | 711.5% | |
Net worth | Rs m | 545 | 104 | 524.3% | |
Long term debt | Rs m | 17 | 3 | 682.0% | |
Total assets | Rs m | 689 | 109 | 634.4% | |
Interest coverage | x | 7.2 | -163.0 | -4.4% | |
Debt to equity ratio | x | 0 | 0 | 130.1% | |
Sales to assets ratio | x | 0.9 | 0 | 20,275.5% | |
Return on assets | % | 12.3 | -1.5 | -809.8% | |
Return on equity | % | 13.3 | -1.6 | -836.5% | |
Return on capital | % | 15.3 | -1.5 | -995.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5 | -36 | -14.6% | |
From Investments | Rs m | -67 | 74 | -89.7% | |
From Financial Activity | Rs m | 63 | -38 | -163.6% | |
Net Cashflow | Rs m | 1 | 0 | -940.0% |
Indian Promoters | % | 70.2 | 16.4 | 428.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 83.6 | 35.7% | |
Shareholders | 1,166 | 2,222 | 52.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | NATURA HUE C |
---|---|---|
1-Day | 8.77% | -1.34% |
1-Month | 26.17% | 3.66% |
1-Year | 113.64% | 43.19% |
3-Year CAGR | 152.58% | 131.92% |
5-Year CAGR | 42.16% | 23.13% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the NATURA HUE C share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of NATURA HUE C the stake stands at 16.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of NATURA HUE C.
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
NATURA HUE C paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of NATURA HUE C.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.